Skip to main content

Table 2 Prognostic value of the NLR in different tumor volume risk groups. Cut-off for the NLR was 4.68

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

  3-year recurrence-free survival 3-year overall survival
  High NLR Low NLR Hazard ratio P value High NLR Low NLR Hazard ratio P value
Small tumor volume (< 15 cm3) 60% 95% 8.16 0.041 75% 90% 0.95 0.964
Intermediate tumor volume (15–70 cm3) 53% 80% 2.77 0.006 68% 82% 1.95 0.052
High tumor volume (>70 cm3) 28% 74% 5.04 < 0.001 33% 84% 4.16 < 0.001